The global heart blocks treatment devices market is anticipated to grow at a CAGR of 5.7% during the forecast period (2023-2030). One of the significant factors accelerating the growth and demand for heart block therapy devices is the rising incidence of cardiovascular disease. As reported by the National Institute of Health (NIH) in August 2022, high-grade atrioventricular (AV) block and sinus node dysfunction (SND) stand as the leading causes of permanent pacemaker implantation. These pacemakers, which are artificial, external, and electric, play a crucial role in supporting patients with intrinsic cardiac pacemaker activity and conducting tissue issues.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/heart-blocks-treatment-devices-market
The global count of individuals relying on pacemakers has reached approximately 3 million, and every year, around 600,000 new pacemakers are implanted. These small battery-operated devices, nestled within the chest, employ cardiac leads to deliver electrical impulses through thin insulated wires. These impulses stimulate the heart’s chambers, facilitating contractions and striving to restore a regular heart rhythm. For instance, in February 2022, Abbott Laboratories announced the critical clinical study for its AVEIR DR i2iTM dual-chamber leadless pacemaker technology, the first patient implants in the globe. The installation of Abbott’s dual-chamber experimental AveirTM leadless pacemaker marks a significant advancement in leadless pacing technology. AV block patients who receive “AV synchronous” pacing therapy by way of algorithms that can detect cardiac activity and change ventricular pacing to sync with the atrium.
Further, in January 2022, Medtronic plc, healthcare technology, launched the MicraTM AV Transcatheter Pacing System (TPS), designed to treat patients with AV block, has obtained approval from the Japanese Ministry of Health. For the purpose to alter pacing, Micra AV contains numerous algorithms that can recognize cardiac motion. A third degree heart block can manifest in a variety of ways, some of that belong potentially fatal. This kind of heart block is typically considered a medical emergency and may call for prompt pacemaker therapy. Different products that are smaller in size can be used in quite different ways than standard left ventricular assist devices (LVAD), they are typically large and necessary for open heart surgery. For instance, in June 2023, Magenta Medical launched a feasibility study exploring the potential application of the globe’s smallest heart pump, the Elevate LVAD, for high-risk percutaneous coronary intervention.
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered-
o By Degree Type
o By Product
o By End-Users
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- includes Abbott Laboratories, Johnson & Johnson, Koninklijke Philips N.V., Medtronic, Inc. and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Heart Blocks Treatment Devices Market Report Segment
By Degree Type
- First-Degree Heart Block
- Second-Degree Heart Block
- Third-Degree Heart Block
By Product
- Transcutaneous Pacing (TCP)
- Pacemaker
- Mediation
By End-Users
- Hospital Testing
- Home treatment
- Clinics
A full report of Heart Blocks Treatment Devices Market available @ https://www.omrglobal.com/industry-reports/heart-blocks-treatment-devices-market
Global Heart Blocks Treatment Devices Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- BIOTRONIK, Inc.
- Boston Scientific Corp.
- Edwards Lifesciences
- Getinge
- Lepu Medical Technology Beijing Co. Ltd.
- LivaNova, PLC
- McKesson Corp.
- MicroPort Scientific Corp.
- Osypka Medical GmbH
- Shree Pacetronix Ltd.
- Jude Medical
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
